Trial · NCT01265550
Results by group84
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 84
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants Achieving at Least a 50% Improvement in the Gastroesophageal Reflux Disease Health-related Quality of Life Index (GERD-HRQL) From Baseline to 12 Months | Medical Treatment Group | 7 | Participants | ||
| Number of Participants Achieving at Least a 50% Improvement in the Gastroesophageal Reflux Disease Health-related Quality of Life Index (GERD-HRQL) From Baseline to 12 Months | Surgical Treatment Group | 18 | Participants | ||
| Number of Participants Achieving at Least a 50% Improvement in the Gastroesophageal Reflux Disease Health-related Quality of Life Index (GERD-HRQL) From Baseline to 12 Months | Placebo Medical Treatment Group | 3 | Participants | ||
| Number of Enrolled Participants With Esophageal Ulceration. | All Enrolled | 0 | Participants | ||
| Number of Enrolled Participants With Reflux Esophagus. | All Enrolled | 4 | Participants | ||
| Number of Enrolled Participants With Eosinophilic Esophagitis | All Enrolled | 16 | Participants | ||
| Number of Enrolled Participants With Active Ulceration of the Stomach and/or Duodenum. | All Enrolled | 3 | Participants | ||
| Number of Enrolled Participants With Neoplasm of the Esophagus, Stomach or Duodenum | All Enrolled | 0 | Participants | ||
| Number of Enrolled Participants With Candida Esophagitis. | All Enrolled | 3 | Participants | ||
| Number of Enrolled Participants With Gastric Outlet Obstruction | All Enrolled | 0 | Participants | ||
| Number of Enrolled Participants With Achalasia | All Enrolled | 2 | Participants | ||
| Number of Enrolled Participants With Aperistalsis | All Enrolled | 0 | Participants | ||
| Number of Enrolled Participants With Distal Esophageal Spasm | All Enrolled | 3 | Participants | ||
| Number of Enrolled Participants With Nutcracker Esophagus | All Enrolled | 2 | Participants | ||
| Number of Enrolled Participants With Ineffective Esophageal Motility | All Enrolled | 1 | Participants | ||
| Number of Enrolled Participants With Rapid Contraction | All Enrolled | 2 | Participants | ||
| Number of Enrolled Participants With Hypertensive Peristalsis | All Enrolled | 3 | Participants | ||
| Number of Enrolled Participants With Jackhammer Esophagus | All Enrolled | 8 | Participants | ||
| Number of Enrolled Participants With Weak Peristalsis I | All Enrolled | 10 | Participants | ||
| Number of Enrolled Participants With Weak Peristalsis II | All Enrolled | 9 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01265550/results